Schonfeld Strategic Advisors »

Taro Pharmaceutical Industries shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Taro Pharmaceutical Industries (TARO) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Taro Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Taro Pharmaceutical Industries held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taro Pharmaceutical Industries by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $459k 11k 41.78
2023-09-30 $245k 6.5k 37.71

More positions owned by Schonfeld Strategic Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
FedEx Corporation (FDX)
Microsoft Corporation (MSFT)
Ishares Msci Brazil Etf Call Option (EWZ)
Ishares Tr U.s. Real Es Etf (IYR)
Mastercard Incorporated Cl A (MA)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Verizon Communications (VZ)
Spdr Ser Tr S&p Biotech (XBI)
Micron Technology (MU)
Johnson Ctls Intl SHS (JCI)

View all positions for Schonfeld Strategic Advisors

Top funds holding Taro Pharmaceutical Industries

Krensavage Asset Management
Dimensional Fund Advisors
Brandes Investment Partners
Vanguard Group
ARK Investment Management
Norges Bank Investment Management
Arrowstreet Capital, Limited Partnership
UBS Group
Bank of New York Mellon
Charles Schwab Investment Management
Swiss National Bank
Citadel Advisors
Barclays
Connor, Clark & Lunn Investment Management
Inspire Advisors

View all funds holding Taro Pharmaceutical Industries